Menu
Back to User profile » Prof. Dr. Vanita Noronha
Papers published by Prof. Dr. Vanita Noronha:
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
Kate S, Chougule A, Joshi A, Noronha V, Patil V, Dusane R, Solanki L, Tiwrekar P, Trivedi V, Prabhash K
Lung Cancer: Targets and Therapy 2019, 10:1-10
Published Date: 29 January 2019
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K
Lung Cancer: Targets and Therapy 2018, 9:1-11
Published Date: 3 January 2018
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K
OncoTargets and Therapy 2017, 10:2903-2908
Published Date: 9 June 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K
OncoTargets and Therapy 2017, 10:1859-1863
Published Date: 28 March 2017
High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy
Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K
Cancer Management and Research 2014, 6:261-265
Published Date: 4 June 2014